Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4204)

Showing 12 of 4204 View All
Showing 60 of 351 pages

Mpox continues to spread in countries with little access to vaccines

Mpox is continuing to circulate in Africa, Asia and Latin America, where access to vaccines is patchy or non-existent. 

Where delivering health care means facing down armed bandits

In northwest Nigeria, some health workers are facing down danger to care for embattled communities.

What misusing antibiotics is really costing us

As antimicrobial resistance rises and some infections become incredibly hard, sometimes impossible, to cure, here’s how the costs of inaction are stacking up.

Retired nurses turn reinforcements at short-staffed Lagos health facilities

As Nigeria grapples with a brain drain of skilled health workers, retired nurses are being redeployed to the healthcare frontlines in the country’s commercial capital. 

“Promising” trial results suggest chikungunya vaccine could be within reach

A phase 3 trial suggests the VLA1553 chikungunya vaccine candidate is safe, well tolerated and provokes strong antibody responses in 99% of recipients.

Madrid conference marks reaching over 1 billion children vaccinated, reviews progress and resolves to tackle challenges

The Global Vaccine Impact Conference closed today, as the Vaccine Alliance marked more than 1 billion children vaccinated through its programmes.

Faster with wings: Ghana’s immunisation rates soar in Zipline-served districts

Drone delivery of vaccines has helped immunisation programmes in remote parts of Ghana’s Western North region bounce back faster than average from the pandemic’s impact, new research says. VaccinesWork visited the Zipline regional hub to find out…

Global Vaccine Impact Conference: Day One & Two Highlights

The Global Vaccine Impact Conference is bringing together some of the biggest names in global immunisation in Madrid from the 13-15 June. Here are some of the key quotes from the first two days.

Vaccine Alliance reaches more than one billion children

Gavi, the Vaccine Alliance, has now facilitated the immunisation of more than one billion children with childhood vaccines.

Spanish Government brings global leaders together to take stock of the state of global vaccination, discuss its future

Global leaders and immunisation experts are coming together to assess the progress of the Vaccine Alliance and discuss the challenges it faces in the future.

11 key stats from Gavi’s Mid-Term Review

In 2019 Gavi set out a list of targets to boost immunisation across the globe for the 2021–25 period. Halfway through the period, how is it measuring up?

“Honestly, it was very exciting”: Gavi’s longest-serving staffer looks back to the very beginning

With Gavi shortly to release its Mid Term Review report, VaccinesWork is in a mood for reflection. We invited Corina Roberts, who joined Gavi in 2000, to sit down with us and take a look back across the decades.

Subscribe to our newsletter